For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
In the latest session, Bicara Therapeutics Inc (NASDAQ: BCAX) closed at $13.01 down -10.28% from its previous closing price of $14.50. In other words, the price has decreased by -$10.28 from its previous closing price. On the day, 2.8 million shares were traded. BCAX stock price reached its highest trading level at $14.76 during the session, while it also had its lowest trading level at $12.455.
Ratios:
For a deeper understanding of Bicara Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 36.01 and its Current Ratio is at 36.01. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wedbush on February 06, 2025, initiated with a Outperform rating and assigned the stock a target price of $31.
On December 06, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $42.
On November 05, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $48.Rodman & Renshaw initiated its Buy rating on November 05, 2024, with a $48 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 16 ’24 when RA CAPITAL MANAGEMENT, L.P. bought 1,833,000 shares for $18.00 per share. The transaction valued at 32,994,000 led to the insider holds 4,303,418 shares of the business.
Flynn James E bought 70,000 shares of BCAX for $1,260,000 on Sep 17 ’24. The Possible Members of 10% Group now owns 897,587 shares after completing the transaction at $18.00 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BCAX now has a Market Capitalization of 707946944 and an Enterprise Value of 268713472.
Stock Price History:
Over the past 52 weeks, BCAX has reached a high of $28.09, while it has fallen to a 52-week low of $11.10. The 50-Day Moving Average of the stock is -4.23%, while the 200-Day Moving Average is calculated to be -29.33%.
Shares Statistics:
For the past three months, BCAX has traded an average of 453.61K shares per day and 639680 over the past ten days. A total of 54.41M shares are outstanding, with a floating share count of 30.89M. Insiders hold about 43.23% of the company’s shares, while institutions hold 55.58% stake in the company. Shares short for BCAX as of 1740700800 were 5607873 with a Short Ratio of 12.36, compared to 1738281600 on 4077688.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
